Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. med. vet. zoot ; 64(3): 11-21, sep.-dic. 2017. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-902177

RESUMO

RESUMEN El virus Epstein-Barr (EBV) es un virus de alta prevalencia en humanos que se asocia con tumores de la línea linfoide B. En caninos se dispone de pocos reportes sobre la presencia del EBV y su rol en esta especie. El objetivo del presente estudio fue determinar la presencia de la proteína latente de membrana del EBV (LMP-1) en tejidos obtenidos de 20 linfomas de caninos cuyo diagnóstico se había realizado durante un periodo de 10 años, entre 2004 y 2014. Los linfomas se reclasificaron mediante las nuevas clasificaciones histopatológicas para linfomas y se sometieron a inmunohistoquímica (IHQ) con los anticuerpos anti-CD79a, anti-CD3, anticuerpos específicos para linfocitos B y T, además de un anti-LMP-1 como marcador de la presencia del EBV. Se encontró que el linfoma más común fue el linfoma nodal de zona T con un 75% de los casos. Al realizar la inmunomarcación se encontraron 18 casos positivos a CD3, 2 casos positivos a CD79a y 6 casos positivos a LMP-1, lo que representa el 30% de positividad del EBV en linfomas. El análisis Ji cuadrado demostró significancia estadística entre la presencia del virus y la presencia del linfoma lo que sugiere, no solamente que el virus está circulando en la población canina, sino que además puede tener relación con la ocurrencia de esta neoplasia. Con relación a las variables demográficas, sólo en la raza Golden Retriever se demostró relación con la presencia del linfoma, pero no con la presencia del virus.


ABSTRACT Epstein Barr virus (EBV) is a human high prevalent virus associated with lymphoid B cells tumors development. In canines, few reports have been published regarding the presence of the virus in dogs but its role in this species remains unclear. The aim of this study was to determine the presence of LMP-1 protein of EBV in 20 canine lymphomas tissues which were previously diagnosed in a period of time between 2004 -2014. Lymphomas were reclassified in accordance with the new histopathological classifications for lymphomas and were stained by IHQ with anti-CD79a, anti-CD3 and anti-LMP-1; in addition, specific antibodies for B lymphocytes, T lymphocytes and EBV biomarker, respectively. It was found that the most common lymphoma was T-zone lymphoma in 75% of the cases of the study. The distribution of the cases regarding the immunostaining was: 18 positive cases with anti-CD3, 2 positive cases with anti-CD79a and 6 positive cases with anti- LMP-1. Positive cases of LMP-1 as a biomarker of the presence of EBV corresponded to the 30% of the cases of the study. Chi-square test showed statistical significance between the presence of the virus and the presence of lymphomas, which suggests not only that the virus is circulating in the canine population but also that could have implications in the development of the disease. Regarding demographic parameters, only the Golden Retriever breed showed a relationship with the presence of lymphoma, but not with the presence of the virus.

2.
Scand J Immunol ; 74(5): 471-81, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21671975

RESUMO

Patients with adenosine deaminase (ADA) deficiency exhibit spontaneous and partial clinical remission associated with somatic reversion of inherited mutations. We report a child with severe combined immunodeficiency (T-B- SCID) due to ADA deficiency diagnosed at the age of 1 month, whose lymphocyte counts including CD4+ and CD8+ T and NK cells began to improve after several months with normalization of ADA activity in Peripheral blood lymphocytes (PBL), as a result of somatic mosaicism caused by monoallelic reversion of the causative mutation in the ADA gene. He was not eligible for haematopoietic stem cell transplantation (HSCT) or gene therapy (GT); therefore he was placed on enzyme replacement therapy (ERT) with bovine PEG-ADA. The follow-up of metabolic and immunologic responses to ERT included gradual improvement in ADA activity in erythrocytes and transient expansion of most lymphocyte subsets, followed by gradual stabilization of CD4+ and CD8+ T (with naïve phenotype) and NK cells, and sustained expansion of TCRγδ+ T cells. This was accompanied by the disappearance of the revertant T cells as shown by DNA sequencing from PBL. Although the patient's clinical condition improved marginally, he later developed a germinal cell tumour and eventually died at the age of 67 months from sepsis. This case adds to our current knowledge of spontaneous reversion of mutations in ADA deficiency and shows that the effects of the ERT may vary among these patients, suggesting that it could depend on the cell and type in which the somatic mosaicism is established upon reversion.


Assuntos
Adenosina Desaminase/metabolismo , Terapia de Reposição de Enzimas , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/terapia , Neoplasias Primárias Desconhecidas/genética , Neoplasias Primárias Desconhecidas/terapia , Imunodeficiência Combinada Severa/genética , Imunodeficiência Combinada Severa/terapia , Adenosina Desaminase/administração & dosagem , Adenosina Desaminase/genética , Adenosina Desaminase/imunologia , Animais , Linfócitos T CD4-Positivos/efeitos dos fármacos , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/metabolismo , Linfócitos T CD4-Positivos/patologia , Linfócitos T CD8-Positivos/efeitos dos fármacos , Linfócitos T CD8-Positivos/imunologia , Linfócitos T CD8-Positivos/metabolismo , Linfócitos T CD8-Positivos/patologia , Bovinos , Contagem de Células , Criança , Pré-Escolar , Análise Mutacional de DNA , Evolução Fatal , Humanos , Imunofenotipagem , Lactente , Células Matadoras Naturais/patologia , Neoplasias Pulmonares/complicações , Neoplasias Pulmonares/fisiopatologia , Neoplasias Pulmonares/secundário , Masculino , Mosaicismo/efeitos dos fármacos , Mutação/genética , Neoplasias Primárias Desconhecidas/complicações , Neoplasias Primárias Desconhecidas/patologia , Neoplasias Primárias Desconhecidas/fisiopatologia , Receptores de Antígenos de Linfócitos T/metabolismo , Imunodeficiência Combinada Severa/complicações , Imunodeficiência Combinada Severa/patologia , Imunodeficiência Combinada Severa/fisiopatologia , Choque Séptico
3.
Rev Invest Clin ; 50(5): 405-12, 1998.
Artigo em Espanhol | MEDLINE | ID: mdl-9949671

RESUMO

OBJECTIVE: To determine the free amino acid pool in plasma and milk in Mexican rural lactating women. METHODS: Twenty-eight women with an age 24 +/- 5.0 (+/- SD) years, weight 50 +/- 4.9 kg and height 148 +/- 4.8 cm were studied under metabolic balance conditions. Subjects were divided into five groups (three groups of lactation at 1st, 3rd and 6th month, one post-weaning group and a control group of non pregnant, non lactating women). Amino acid analyses of the diet and of plasma and milk samples were performed using an automated amino acid analyzer. RESULTS: Differences were observed between the lactation groups and the other groups: aspartate increased at the 6th month (p < 0.05) while leucine, valine and isoleucine declined in the 3rd month (p < 0.05). In milk, valine, proline and taurine decreased at 6 months (p < 0.05), while serine and threonine raised at 3 months. Plasma levels were > 4 fold greater than milk levels for branched chain amino acids and for the basic, aromatic and neutral amino acids. In contrast, glutamate was 40 fold higher in milk than plasma and it was the predominant amino acid in the free pool of milk. CONCLUSIONS: Our results suggest that the metabolic use of amino acids and the presence of specific amino acid transport systems during lactation, contribute to specific concentrations of free amino acids in milk that were not associated with the pool of free amino acids in plasma.


Assuntos
Aminoácidos/análise , Lactação , Leite Humano/química , Saúde da População Rural , Adulto , Aminoácidos/sangue , Animais , Feminino , Humanos , México , Gravidez
4.
Rev Invest Clin ; 48(6): 473-8, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-9028153

RESUMO

Human milk lipids are the main source of energy to support optimum growth of the breast-fed infant. The content and composition of milk lipids come from three main sources of fatty acids: the diet, mobilization of body fat stores and fatty acid synthesis de novo by the mammary gland. On account of these, the consumption and composition of the lipids from the diet and also the nutritional state, specifically the body fat percentage of the lactating woman, are elements that maintain a close relation with the content and composition of milk lipids which translates into the energy content given to the baby. The evidence suggests that the body fat stores significantly provide the demand imposed by lactation, and under suboptimal nutritional conditions where body fat stores are depleted, dietary lipid consumption is essential. It is necessary to elucidate the physiological regulatory mechanisms involved in the utilization of dietary lipids on milk synthesis. This information will be of great practical value, since it may allow the development of optimum diets for lactating women.


Assuntos
Gorduras na Dieta/administração & dosagem , Lactação , Lipídeos , Leite Humano/química , Tecido Adiposo , Composição Corporal , Ácidos Graxos/biossíntese , Feminino , Humanos , Lactação/metabolismo , Metabolismo dos Lipídeos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...